AAAAAA
Results:
1-8
|
Results: 8
Authors:
Cutuli, B
Janvier, M
de la Rochefordiere, A
Julien, JP
Isambert, N
Alzieu, C
Kerbrat, P
de Lafontan, B
van Lemmens, L
Cure, H
Ganem, G
Baume, D
Le Mevel, A
Lorthoraly, A
de Gislain, C
Marchal, C
Chevelle, C
Lauche, H
Serin, D
Citation: B. Cutuli et al., Leukemias and preleukemic states developing after treatment of breast cancer, PRESSE MED, 29(3), 2000, pp. 135-138
Authors:
Girinsky, T
Benhamou, E
Bourhis, JH
Dhermain, F
Guillot-Valls, D
Ganansia, V
Luboinski, M
Perez, A
Cosset, JM
Socie, G
Baume, D
Bouaouina, N
Briot, E
Beaudre, A
Bridier, A
Pico, JL
Citation: T. Girinsky et al., Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies, J CL ONCOL, 18(5), 2000, pp. 981-986
Authors:
Baume, D
Citation: D. Baume, On becoming an innovative university teacher, STUD HIGH E, 25(1), 2000, pp. 117-118
Authors:
Vey, N
Blaise, D
Lafage, M
Olive, D
Viens, P
Baume, D
Camerlo, J
Stoppa, AM
Gabus, R
Brandely, M
Hercend, T
Maraninchi, D
Citation: N. Vey et al., Treatment of chronic myelogenous leukemia with interleukin-2: A phase II study in 21 patients, J IMMUNOTH, 22(2), 1999, pp. 175-181
Authors:
Chapel, F
Baume, D
Bereder, JM
Citation: F. Chapel et al., Unusual vascular changes in the red pulp of the spleen accompanying breastcarcinoma metastasis, PATH RES PR, 195(1), 1999, pp. 53-56
Authors:
Dorval, T
Negrier, S
Chevreau, C
Avril, MF
Baume, D
Cupissol, D
Oskam, R
de Peuter, R
Vinke, J
Herrera, L
Escudier, B
Citation: T. Dorval et al., Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma, CANCER, 85(5), 1999, pp. 1060-1066
Authors:
Maraninchi, D
Vey, N
Viens, P
Stoppa, AM
Archimbaud, E
Attal, M
Baume, D
Bouabdallah, R
Demeoq, F
Fleury, J
Michallet, M
Olive, D
Reiffers, J
Sainty, D
Tabilio, A
Tiberghien, P
Brandely, M
Hercend, T
Blaise, D
Citation: D. Maraninchi et al., A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia, LEUK LYMPH, 31(3-4), 1998, pp. 343-349
Authors:
Gravis, G
Viens, P
Delva, R
Baume, D
Blaise, D
Ternier, F
Houvenaeghel, G
Brandely, M
Resbeut, M
Maraninchi, D
Citation: G. Gravis et al., rIL-2 in metastatic soft tissue sarcomas refractory to chemotherapy: Response and enhancement of further chemosensitivity, ANTICANC R, 18(5B), 1998, pp. 3699-3704
Risultati:
1-8
|